Access

Article


Nature Medicine 8, 1004 - 1010 (2002)
Published online: 29 July 2002 | doi:10.1038/nm744

Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis

Atsushi Otani1, Karen Kinder1, Karla Ewalt2, Francella J. Otero2, Paul Schimmel2 & Martin Friedlander1


Adult bone marrow (BM) contains cells capable of differentiating along hematopoietic (Lin+) or non-hematopoietic (Lin-) lineages. Lin- hematopoietic stem cells (HSCs) have recently been shown to contain a population of endothelial precursor cells (EPCs) capable of forming blood vessels. Here we show that intravitreally injected Lin- BM cells selectively target retinal astrocytes, cells that serve as a template for both developmental and injury-associated retinal angiogenesis. When Lin- BM cells were injected into neonatal mouse eyes, they extensively and stably incorporated into forming retinal vasculature. When EPC-enriched HSCs were injected into the eyes of neonatal rd/rd mice, whose vasculature ordinarily degenerates with age, they rescued and maintained a normal vasculature. In contrast, normal retinal angiogenesis was inhibited when EPCs expressing a potent angiostatic protein were injected. We have demonstrated that Lin- BM cells and astrocytes specifically interact with one another during normal angiogenesis and pathological vascular degeneration in the retina. Selective targeting with Lin- HSC may be a useful therapeutic approach for the treatment of many ocular diseases.


MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Stem cells go for the eyes
Nature Medicine News and Views (01 Sep 2002)

RESEARCH
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
The EMBO Journal Article (15 Jul 1999)